Skip to main content
Top
Published in: Virology Journal 1/2010

Open Access 01-12-2010 | Research

Evaluation of an immunochromatographic assay for the detection of anti-hepatitis A virus IgM

Authors: Hyeok-Jin Lee, Hye Sook Jeong, Byung-Ki Cho, Mi-Jeong Ji, Ji-Ha Kim, An-Na Lee, Kyoung-Ryul Lee, Doo-Sung Cheon

Published in: Virology Journal | Issue 1/2010

Login to get access

Abstract

Background

Hepatitis A virus (HAV) is a causative agent of acute hepatitis, which is transmitted by person-to-person contact and via the faecal-oral route. Acute HAV infection is usually confirmed by anti-HAV IgM detection. In order to detect anti-HAV IgM in the serum of patients infected with HAV, we developed a rapid assay based on immunochromatography (ICA) and evaluated the sensitivity of this assay by comparing it with a commercial microparticle enzyme immunoassay (MEIA) that is widely used for serological diagnosis.

Results

The newly developed ICA showed 100% sensitivity and specificity when used to test 150 anti-HAV IgM-positive sera collected from infected patients and 75 negative sera from healthy subjects. Also, the sensitivity of ICA is about 10 times higher than MEIA used in this study by determining end point to detect independent on infected genotype of HAV. In addition, the ICA was able to detect 1 positive sample from among 50 sera from acute hepatitis patients that had tested negative for anti-HAV IgM using the MEIA.

Conclusion

Conclusively, ICA for the detection of anti-HAV IgM will be very effective for rapid assay to apply clinical diagnosis and epidemiological investigation on epidemics due to the simplicity, rapidity and specificity.
Literature
1.
go back to reference Hollinger F, Ticehurst J: Hepatitis A virus. In Fields Virology. 3rd edition. Edited by: Fields BN, Knipe DM, Howley PM. Philadelphia, Pennsylvania: Lippincott-Raven Publishers; 1996:735-782. Hollinger F, Ticehurst J: Hepatitis A virus. In Fields Virology. 3rd edition. Edited by: Fields BN, Knipe DM, Howley PM. Philadelphia, Pennsylvania: Lippincott-Raven Publishers; 1996:735-782.
2.
go back to reference Hussain Z, Das BC, Husain SA, Asim M, Chattopadhyay S, Malik A, Theamboonlers A, Kar P: Hepatitis A viral genotypes and clinical relevance: Clinical and molecular characterization of hepatitis A virus isolates from northern India. Hepatol Res 2005, 32: 16-24. 10.1016/j.hepres.2005.01.014PubMedCrossRef Hussain Z, Das BC, Husain SA, Asim M, Chattopadhyay S, Malik A, Theamboonlers A, Kar P: Hepatitis A viral genotypes and clinical relevance: Clinical and molecular characterization of hepatitis A virus isolates from northern India. Hepatol Res 2005, 32: 16-24. 10.1016/j.hepres.2005.01.014PubMedCrossRef
3.
go back to reference Rezende G, Roque-Afonso AM, Samuel D, Gigou M, Nicand E, Ferre V, Dussaix E, Bismuth H, Feray C: Viral and clinical factors associated with the fulminant course of hepatitis A infection. J Gastroenterol Hepatol 2003, 38: 613-618. Rezende G, Roque-Afonso AM, Samuel D, Gigou M, Nicand E, Ferre V, Dussaix E, Bismuth H, Feray C: Viral and clinical factors associated with the fulminant course of hepatitis A infection. J Gastroenterol Hepatol 2003, 38: 613-618.
4.
go back to reference Joussemet M, Bourin P, Lebot O, Fabre G, Deloince R: Evolution of hepatitis A antibodies prevalence in young French military recruits. Eur J Epidemiol 1992, 8: 289-291. 10.1007/BF00144816PubMedCrossRef Joussemet M, Bourin P, Lebot O, Fabre G, Deloince R: Evolution of hepatitis A antibodies prevalence in young French military recruits. Eur J Epidemiol 1992, 8: 289-291. 10.1007/BF00144816PubMedCrossRef
5.
go back to reference Stroffolini T, D'Amelio R, Matricardi PM, Chionne P, Napoli A, Rapicetta M, Crateri S, Pasquini P: The changing epidemiology of hepatitis A in Italy. Ital J Gastroenterol 1993, 25: 372-374.PubMed Stroffolini T, D'Amelio R, Matricardi PM, Chionne P, Napoli A, Rapicetta M, Crateri S, Pasquini P: The changing epidemiology of hepatitis A in Italy. Ital J Gastroenterol 1993, 25: 372-374.PubMed
6.
go back to reference Yang NY, Yu PH, Mao ZX, Chen NL, Chai SA, Mao JS: Inapparent infection of hepatitis A virus. Am J Epidemiol 1988, 127: 599-604.PubMed Yang NY, Yu PH, Mao ZX, Chen NL, Chai SA, Mao JS: Inapparent infection of hepatitis A virus. Am J Epidemiol 1988, 127: 599-604.PubMed
7.
go back to reference Aalto SM, Linnavuori H, Peltola E, Vuori B, Weissbrich J, Schubert L, Hedman L, Hedman K: Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection. J Med Virol 1998, 56: 186-191. 10.1002/(SICI)1096-9071(199811)56:3<186::AID-JMV2>3.0.CO;2-3PubMedCrossRef Aalto SM, Linnavuori H, Peltola E, Vuori B, Weissbrich J, Schubert L, Hedman L, Hedman K: Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection. J Med Virol 1998, 56: 186-191. 10.1002/(SICI)1096-9071(199811)56:3<186::AID-JMV2>3.0.CO;2-3PubMedCrossRef
8.
go back to reference Bower WA, Nainan OV, Han X, Margolis HS: Duration of viremia in hepatitis A virus infection. J Infec Dis 2000, 182: 12-17. 10.1086/315701CrossRef Bower WA, Nainan OV, Han X, Margolis HS: Duration of viremia in hepatitis A virus infection. J Infec Dis 2000, 182: 12-17. 10.1086/315701CrossRef
9.
go back to reference Castaneda-Ibarra F, Ruiz-Maya L, Campos-Rodriguez R, Garcia Latorre E: Polyclonal activation of B lymphocytes in patients with amoebic hepatic abscess. Arch Invest Med 1991, 22: 13-17. Castaneda-Ibarra F, Ruiz-Maya L, Campos-Rodriguez R, Garcia Latorre E: Polyclonal activation of B lymphocytes in patients with amoebic hepatic abscess. Arch Invest Med 1991, 22: 13-17.
10.
go back to reference Morgan-Capner P, Tedder RS, Mace JE: Reactivity for rubella-specific IgM in sera from patients with infectious mononucleosis. Lancet 1983,1(8324):589. 10.1016/S0140-6736(83)92839-8PubMedCrossRef Morgan-Capner P, Tedder RS, Mace JE: Reactivity for rubella-specific IgM in sera from patients with infectious mononucleosis. Lancet 1983,1(8324):589. 10.1016/S0140-6736(83)92839-8PubMedCrossRef
11.
go back to reference Nobutoki T, Hori H, Higashigawa M, Azuma E, Sakurai M, Yoshizumi T, Nunoue T: A case of prolonged human parvovirus B19 DNA-emia associated with polyclonal B-cell activation. Acta Paediatr Jap 1996, 38: 348-351.CrossRef Nobutoki T, Hori H, Higashigawa M, Azuma E, Sakurai M, Yoshizumi T, Nunoue T: A case of prolonged human parvovirus B19 DNA-emia associated with polyclonal B-cell activation. Acta Paediatr Jap 1996, 38: 348-351.CrossRef
12.
go back to reference Robertson BH, Khanna B, Nainan OV, Margolis HS: Epidemiologic patterns of wild-type hepatitis A virus determined by genetic variation. J Infect Dis 1991, 163: 286-292.PubMedCrossRef Robertson BH, Khanna B, Nainan OV, Margolis HS: Epidemiologic patterns of wild-type hepatitis A virus determined by genetic variation. J Infect Dis 1991, 163: 286-292.PubMedCrossRef
13.
go back to reference Jilg W: Adult use of hepatitis A vaccine in developed countries. Vaccine 1993,11(Suppl):S6-S8. 10.1016/0264-410X(93)90150-VPubMedCrossRef Jilg W: Adult use of hepatitis A vaccine in developed countries. Vaccine 1993,11(Suppl):S6-S8. 10.1016/0264-410X(93)90150-VPubMedCrossRef
14.
15.
go back to reference Liaw YF, Yang CY, Chu CM, Huang MJ: Appearance and persistence of hepatitis A IgM antibody in acute clinical hepatitis A observed in an outbreak. Infection 1986, 14: 156-158. 10.1007/BF01645253PubMedCrossRef Liaw YF, Yang CY, Chu CM, Huang MJ: Appearance and persistence of hepatitis A IgM antibody in acute clinical hepatitis A observed in an outbreak. Infection 1986, 14: 156-158. 10.1007/BF01645253PubMedCrossRef
16.
go back to reference Stapleton JT, Frederick J, Meyer B: Hepatitis A virus attachment to cultured cell lines. J Infect Dis 1991, 164: 1098-1103.PubMedCrossRef Stapleton JT, Frederick J, Meyer B: Hepatitis A virus attachment to cultured cell lines. J Infect Dis 1991, 164: 1098-1103.PubMedCrossRef
17.
go back to reference Hess G, Faatz E, Melchior W, Bayer H: Analysis of immunoassays to detect antibodies to hepatitis A virus (anti-HAV) and anti-HAV immunoglobulin M. J Virol Meth 1995, 51: 221-228. 10.1016/0166-0934(94)00108-SCrossRef Hess G, Faatz E, Melchior W, Bayer H: Analysis of immunoassays to detect antibodies to hepatitis A virus (anti-HAV) and anti-HAV immunoglobulin M. J Virol Meth 1995, 51: 221-228. 10.1016/0166-0934(94)00108-SCrossRef
18.
go back to reference Fishman LN, Jonas MM, Lavine JE: Update on viral hepatitis in children. Ped Clin N Am 1996,43(1):57-74. 10.1016/S0031-3955(05)70397-7CrossRef Fishman LN, Jonas MM, Lavine JE: Update on viral hepatitis in children. Ped Clin N Am 1996,43(1):57-74. 10.1016/S0031-3955(05)70397-7CrossRef
19.
go back to reference Shao ZJ, Xu DZ, Yan YP, Li JH, Zhang JX, Zhang ZY, Pan BR: Detection of anti-HAV antibody with dot immunogold filtration assay. World J Gastroenterol 2003, 9: 1508-1511.PubMedPubMedCentralCrossRef Shao ZJ, Xu DZ, Yan YP, Li JH, Zhang JX, Zhang ZY, Pan BR: Detection of anti-HAV antibody with dot immunogold filtration assay. World J Gastroenterol 2003, 9: 1508-1511.PubMedPubMedCentralCrossRef
20.
go back to reference Gomara MJ, Riedemann S, Vega I, Ibarra H, Ercilla G, Haro I: Use of linear and multiple antigenic peptides in the immunodiagnosis of acute hepatitis A virus infection. J Immunol Meth 2000, 234: 23-34. 10.1016/S0022-1759(99)00196-9CrossRef Gomara MJ, Riedemann S, Vega I, Ibarra H, Ercilla G, Haro I: Use of linear and multiple antigenic peptides in the immunodiagnosis of acute hepatitis A virus infection. J Immunol Meth 2000, 234: 23-34. 10.1016/S0022-1759(99)00196-9CrossRef
Metadata
Title
Evaluation of an immunochromatographic assay for the detection of anti-hepatitis A virus IgM
Authors
Hyeok-Jin Lee
Hye Sook Jeong
Byung-Ki Cho
Mi-Jeong Ji
Ji-Ha Kim
An-Na Lee
Kyoung-Ryul Lee
Doo-Sung Cheon
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2010
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-7-164

Other articles of this Issue 1/2010

Virology Journal 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.